FSSAI warns HP nutraceutical firms launches drive to curb menace of spurious products
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(This story has not been edited by THE WEEK and is auto-generated from a PTI
India News: NEW DELHI: India's drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Gennova Bi.
India's drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Genova.
Omicron specific mRNA-based booster vaccine developed in India-
As per DelveInsight, the global Immunomodulators market is estimated to grow at a CAGR of 5.19% during the forecast period from 2023 to 2028. The rising